licoricidin and Colonic-Neoplasms

licoricidin has been researched along with Colonic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for licoricidin and Colonic-Neoplasms

Article	Year
Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy. Toxicology and applied pharmacology, 2017, 07-01, Volume: 326 Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzopyrans; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Glycosylation; Humans; Inhibitory Concentration 50; Male; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays	2017

Article

Year

Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.

Toxicology and applied pharmacology, 2017, 07-01, Volume: 326

Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzopyrans; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Glycosylation; Humans; Inhibitory Concentration 50; Male; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays

2017